Overview

Client is a $233M group of wholly-owned group of life-sciences companies that provide its customers with end-to-end solutions that encompass tools, services and “Multi-Ome” diagnostics including genome, microbiome and beyond.

Approach

At the invitation of the CEO, COO and BOD, Paragon served as a bridge between the CMO and technology organizations, simultaneously conducting a technical audit of key systems and identifying data events and KPIs that comprise a 360 degree B2B2C customer journey mapping across 4 global companies and multiple product lines. Paragon served as interim CTO while the company augmented its technology team. Lead innovation to explore additional data ROI e.g. synthetic data products (privacy compliant AI training data.)

Results

Revenue growth 39% Year-Over-Year (Q2-2022)

Paragon recommended and architected updates to 10 key systems globally (3 needed upgrades and 7 missing completely  from prior state) Client was able to track customer lifetime value (CLTV,) customer acquisition cost (CaC) and return on advertising and marketing (ROAS/ROMI) for the first time, across divisions and companies.